According to PANews, Singapore-based orthopedic medical group Basel Medical, listed on Nasdaq under the ticker BMGL, has announced a suspension of its Bitcoin acquisition strategy. The decision comes in response to ongoing uncertainties surrounding U.S. regulations on digital assets. The company cited the lack of clarity in the regulatory environment as a key factor influencing its decision to pause further investments in Bitcoin.